The TAK1-NF-κB axis as therapeutic target for AML.
Bosman MC, Schepers H, Jaques J, Brouwers-Vos AZ, Quax WJ, Schuringa JJ, Vellenga E.
Bosman MC, et al. Among authors: vellenga e.
Blood. 2014 Nov 13;124(20):3130-40. doi: 10.1182/blood-2014-04-569780. Epub 2014 Oct 6.
Blood. 2014.
PMID: 25287709
Free article.